Esophageal cancer is the most markedly increasing tumor entity in Western countries. Due to very poor 5-year-survival, new therapeutic approaches are mandatory. Peripheral benzodiazepine receptors (PBR) have been implicated in growth control of various tumor models, but they have not been studied ye
Differential involvement of the Fas receptor/ligand system in p53-dependent apoptosis in human prostate cancer cells
β Scribed by Isao Hara; Hideaki Miyake; Shoji Hara; Soichi Arakawa; Sadao Kamidono
- Publisher
- John Wiley and Sons
- Year
- 2000
- Tongue
- English
- Weight
- 588 KB
- Volume
- 45
- Category
- Article
- ISSN
- 0270-4137
No coin nor oath required. For personal study only.
π SIMILAR VOLUMES
## Abstract It has been clearly established that receptor activator of nuclear factor kappa B ligand (RANKL) is a key cytokine involved in the differentiation of osteoclastic precursors of the monocytic/macrophagic lineage. However, relatively little information is available on the ability of RANKL
The acquisition of epithelial-neuroendocrine differentiation (ND) is a peculiarity of human advanced, androgen-independent, prostate cancers. The HOX genes are a network of transcription factors controlling embryonal development and playing an important role in crucial adult eukaryotic cell function
BACKGROUND. We analyzed the cytotoxic properties of the new heterodinucleoside phosphate dimer 5-FdU-NOAC, which is composed of the cytotoxic drugs 5-FdU and N 4octadecyl-1-β€-D-arabinofuranosylcytosine (NOAC) against human prostate tumor cells. METHODS. 5-FdU-NOAC effects on cell proliferation, cell